<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font26 { font-size : 26; }</style>
 <body>
  <p>
   <span class="font32">patients </span>
   <span class="font26">clinical </span>
   <span class="font26">COVID- </span>
   <span class="font23">antiviral </span>
   <span class="font22">treatment </span>
   <span class="font22">coronavirus </span>
   <span class="font21">viral </span>
   <span class="font21">â€". </span>
   <span class="font20">{border-style </span>
   <span class="font19">drugs </span>
   <span class="font19">px;} </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">chloroquine </span>
   <span class="font18">respiratory </span>
   <span class="font17">RNA </span>
   <span class="font17">severe </span>
   <span class="font17">trials </span>
   <span class="font17">SARS-CoV- </span>
   <span class="font16">LPV/r </span>
   <span class="font16">activity </span>
   <span class="font16">drug </span>
   <span class="font16">virus </span>
   <span class="font15">disease </span>
   <span class="font15">efficacy </span>
   <span class="font15">patients. </span>
   <span class="font15">remdesivir </span>
   <span class="font15">syndrome </span>
   <span class="font15">day </span>
   <span class="font15">favipiravir </span>
   <span class="font15">patient </span>
   <span class="font15">use </span>
   <span class="font14">However, </span>
   <span class="font14">acute </span>
   <span class="font14">approved </span>
   <span class="font14">treat </span>
   <span class="font14">treated </span>
   <span class="font14">cell </span>
   <span class="font14">combination </span>
   <span class="font14">hydroxychloroquine </span>
   <span class="font14">protease </span>
   <span class="font14">px; </span>
   <span class="font14">results </span>
   <span class="font14">study </span>
   <span class="font14">{font-family </span>
   <span class="font13">COVID-. </span>
   <span class="font13">currently </span>
   <span class="font13">evaluated </span>
   <span class="font13">font-size </span>
   <span class="font13">group </span>
   <span class="font13">lung </span>
   <span class="font13">observed </span>
   <span class="font13">therapies </span>
   <span class="font13">trial </span>
   <span class="font13">Furthermore, </span>
   <span class="font13">HIV </span>
   <span class="font13">addition, </span>
   <span class="font13">animal </span>
   <span class="font13">control </span>
   <span class="font13">double; </span>
   <span class="font13">human </span>
   <span class="font13">infection </span>
   <span class="font13">inhibitors </span>
   <span class="font13">mild </span>
   <span class="font13">received </span>
   <span class="font12">Antiviral </span>
   <span class="font12">China </span>
   <span class="font12">East </span>
   <span class="font12">Middle </span>
   <span class="font12">Remdesivir </span>
   <span class="font12">Res; </span>
   <span class="font12">and/or </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">broad-spectrum </span>
   <span class="font12">case </span>
   <span class="font12">clearance </span>
   <span class="font12">conducted </span>
   <span class="font12">considered </span>
   <span class="font12">coronaviruses. </span>
   <span class="font12">data </span>
   <span class="font12">evaluate </span>
   <span class="font12">including </span>
   <span class="font12">influenza </span>
   <span class="font12">inhibit </span>
   <span class="font12">novel </span>
   <span class="font12">replication </span>
   <span class="font12">report </span>
   <span class="font12">reported </span>
   <span class="font12">solid; </span>
   <span class="font12">studies </span>
   <span class="font12">symptoms </span>
   <span class="font12">time </span>
   <span class="font12">vitro </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">(nâ€‰=â€‰), </span>
   <span class="font12">Antimicrob </span>
   <span class="font12">China. </span>
   <span class="font12">Favipiravir </span>
   <span class="font12">IL- </span>
   <span class="font12">MERS-CoV </span>
   <span class="font12">Med; </span>
   <span class="font12">able </span>
   <span class="font12">associated </span>
   <span class="font12">bold </span>
   <span class="font12">care </span>
   <span class="font12">courier; </span>
   <span class="font12">culture, </span>
   <span class="font12">develop </span>
   <span class="font12">different </span>
   <span class="font12">em; </span>
   <span class="font12">hospital </span>
   <span class="font12">ill </span>
   <span class="font12">mouse </span>
   <span class="font12">ongoing </span>
   <span class="font12">options </span>
   <span class="font12">outcome </span>
   <span class="font12">oxygen </span>
   <span class="font12">patients, </span>
   <span class="font12">pneumonia </span>
   <span class="font12">potential </span>
   <span class="font12">profile </span>
   <span class="font12">pt;} </span>
   <span class="font12">recovery </span>
   <span class="font12">reduce </span>
   <span class="font12">safety </span>
   <span class="font12">tocilizumab </span>
   <span class="font12">treatment. </span>
   <span class="font12">twice </span>
   <span class="font12">vs. </span>
  </p>
 </body>
</html>
